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ABSTRACT 
The teratogenic potential of Sodium Dodecylbenzene 
Sulfonate, a biodegradable anionic surfactant, has been 
investigated in the ICR CD-1 strain of mice. Levels at 
which nonnal blastocyst implantation would occur were deter-
mined by the oral administration of a LAS-distilled, deion-
ized water suspension to 3 to 5 month old pregnant females, 
from day 0 to 7 of gestation. Doses ranged from 0 to 300 
mg/kg at 25 mg/kg increments. The highest dosage level at 
which the number of blastocyst implants equalled that of 
controls was 225 mg/kg. 
In a subsequent 17 day study, doses of 225, 100, 5, 
and 0 mg/kg LAS were administered orally by intubation to 
2~ month old pregnant females. No significant visceral 
defects or skeletal anomalies were observed at the gross 
level. The increased number of fetal deaths and resorptions 
observed suggests that embryotoxicity was evident after 
early exposure of the embryo to the surfactant. Results are 
compared with mammalian studies ~n which mode and timing 
of administration, as well as species tolerance, signifi-
cantly affected the type of results which were observed. 
Human teratogenic potential appears moot, since rela-
tively high concentrations of the surfactant were required 
iv 
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to produce deleterious effects. 
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INTRODUCTION 
Linear alkylbenzene sulfonate (LAS) is a biodegrad-
able, anionic surfactant commonly used in commer~ial deter-
gents (Swisher, 1970; Harris et ~·, 1971). Becaus.e it is 
a synthetic surfactant, studies of its effects upon verte-
brates, particularly mammals, have been undertaken to de-
termine toxic and/or teratogenic levels.· The question o.f 
its teratogenic potential is quite complex, and has led to 
conflicting conclusions. 
Teratology, according to Webster's Dictionary, is 
"the scientific study of biological monstrosities and mal-
formations." These malformations are normally produced dur-
ing development. Thus, compounds that would ordinarily be 
relatively harmless to adults, may have deleterious effects 
on developing organisms because the fetu'S lacks the de-
toxifying capabilities of adults (DiPaolo, 1969). J:Iowever, 
limitations arise in subsequent testing due to species tol-
erance. Past studies have shown that not all vertebrates, 
or even mammals, are equally susceptible to a teratogen. 
A good example.is the thalidomide incident of the 1960•s. 
Although initial testing showed that thalidomide did not 
harm fetal mice and rats, it was teratogenic to humans 
(Lenz, 1966). Thus, conclusi~ns drawn from animal testing 
2 
are somewhat uncertain when compared with humans; no speci-
fic protocol for such tests can be outlined (Brent~ 1972). 
A number of species must, therefore, be tested (Wilson, 
1973). 
Before considering the development of this environ-
mental problem, a brief description of the surfactant and 
its properties is necessary. Surfactants, or surface active 
agents, are arnphipathic molecules characterized by a polar, 
hydrophilic, and a non-polar, hydrophobic portion. Because 
of the dual nature of such a molecule, surfactants are able 
to lower surface energy along ari interface. They are emul-
sifying agents and hence are found in most cle~ing agents 
(Haney ~ al., 1954). Surfactants are divided into three 
types: anionic, nonionic, and cationic~ The character of 
the polar group determines the class to which the specific 
molecule belongs. Linear alkylbenzene sulfonate is anionic 
due to the negative charge of its sulfonate group. The non-
polar portion of the molecule consists of an alkyl chain at-
tached to a benzene ring. 
The nature of the alkyl group varies greatly in com-
mercial surfactants, and significantly influences its chem-
ical and biological action (Swisher, i963; Amend~, 1967). 
The majority of alkylbenzene sulfonates (ABS) used before 
1965 contained a tetrapropylene group as the alkyl chain 
(Swisher, 1970). 
_ .. 
Due to the branching of the carbon skeleton, this compound 
was difficult for sewage bacteria to breakdown (Sw'isher, 
1963). This unfavorable property of ABS prompted its re-
placement by a more biodegradable substance, LAS. 
Conversion to .LAS occurred in the middle Sixties, 
since LAS had been found to be more easily degraded by bact-
eria. One study performed by Halvorson and Isaque (1968) 
showed that 93% of a commercial preparation and 97.5% of an 
' 11.3 preparation of LAS (an isomeric mixture containing an 
average carbon chain length of 11.3) were metabolized into 
non-detectable units by bacteria within 96 hours. In a 
similar study of the bacterial metabolism of dodecyl- and 
undecylbenzene-p-sulfonate, Willetts and. Cain (1972) pro~ 
posed a cleavage of the alkyl chain and the sulfonate group 
from the phenyl ring, with their subsequent metabolism into 
normal waste products. According to this scheme,_ the sul-
fite is oxidized to sulfate, the alkyl chain undergoes beta-
oxidation, and the benzene ring is oxidized to succinate and 
acetyl CoA (Figure 1). 
Ideally, LAS is dodecylbenzene sulfonate, but cornmer-
3 
Bacterial degradation scheme of LAS according 
to Willetts and Cain (1972). 
Figure 1 
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cially prepared LAS characteristically represents a mixture 
of straight chain carbon atoms ranging in number from 8 to 
16. The majority of position isomers are secondary, with 
the benzene ring attached to the second carbon atom of the 
alkyl chain. 
(LAS) 
The position of the phenyl ring and the chain length 
of the alkyl group can alter the detergency and biodegrad-
ability of the compound (Rubinfeld et al., 1964; McAteer and 
Kinnard, 1967). The mechanism of detergency is not well 
known. Certainly micellar fonnation and solubilization are 
key processes in detergency, but opinions differ with res-
pect to the type of micellar organization and the energy 
requirements for that ronnation (Anacker, 1970). 
Biodegradability in mammals was established by 
Michael (1968), who followed 35s-LAS in albino rats. His 
results showed that 92% of the label was excreted into the 
urine within 48 hours, while 35s-ABS accumulated in the · 
liver and was excreted in the feces. Michael also establish-
ed that both LAS and ABS were absorbed through the gastro-
intestinal tract and were probably transported by the venous 
blood. The extent to which LAS had been degraded was deter-
_ ... 
mined by Nuclear Magnetic Resonance ( Nr-.1R) and showed that 
60-65~ of the LAS excreted in the urine after 72 hours was 
6 
sulf ophenyl butanoic acid and sulf ophenyl pentanoic acid. 
These two compounds suggest omega- followed by beta-oxida-
tion. Thus, the LAS molecule is relatively intact in the 
mammal, and if toxic or teratogenic effects are fowid, they 
can be attributed to either the intact molecule or one of 
its early degradation ·products. 
The toxicity research with respect tef LAS is most 
abundant for fish. Swisher (1964) detennined the toxicity of 
dodecyl- and undecylbenzene-p-sulfonate to fish and showed 
that the 12 carbon chain had a 4g hour TLtn (Median Tolerance 
Limit) of J.O ppm, while the 11 carbon chain was 75 ppm. A 
more refined t.est of toxicity and structure was reported by 
Hirsch (1963) who tested various structural isomers on the 
fish, Goldorfen, Idus idus. His results showed that greater 
. ---:--- -...-
toxicity as evidenced by lower TLm 's was obtained as the 
chain length increased and the position·of the phenyl ring 
crone closer to the primary carbon. Similar results of the 
higher toxicity of a primary 12 carbon isomer of LAS have 
been reported in other species of fish (Borstlap, 1967). 
The work of Manner and Dewese ( 1974) has demonstrated that 
various mixtures of isomers differ in toxicity; a LAS pre-
paration having an average carbon length of 11.8 was more 
toxic than one having a carbon length of 11.2. Although 
these results suggest an environmental hazard on the part of 
__ .. 
r 
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these compounds, the hazard may not be relevant to mai"unals, 
since the manner of mammalian exposure to LAS is not the 
sa~e as fish. Exposure to a developing mammal is only 
through the circulatory system of the mother. To achieve 
this, the·mother must ingest the LAS or the material must be 
absorbed through the skin. The effects of LAS absorbed 
through the skin cannot be discounted, but the amount ab-
sorbed in relation to other modes of entry is minimal (Gale, 
1974). 
Two sources of oral exposure to the surfactant are 
possible: one from residual amounts in fresh water supplies, 
the other rrom inadequately rinsed dishes after washing. 
The United States Government has set allowable levels of LAS 
in waterways at 0.5 ppm {'Swisher, 1970). Tests of the 
Calumet' River conducted by the Federal Water Pollution 
Control Administratiori during ·1966 snowed an average Methyl-
ene Blue Active .$ubst,a,nc~ (MEAS) of approximately 0.5 ppm •. 
The reaction between Methyl~ne Blue and the anionic surfact-
ant involves a colorimetric assay or the salt fanned from 
the two substances ( &'lfisher, 1970). The value obtained from 
this test agrees with :f'igures of MBAS obtained rrom the 
Illinois River (Sullivan and Evans, 1968; Sullivan and 
Swisher, 1969), the bulk of which represents LAS (Rickert 
and Hunter, 197J). 
Residual &~cunts of LAS left on improperly rinsed 
dishes and glassware depend upon a number of factors. A 
_ ... 
variety of reports have listed different figures for the 
average human intake, with a reliable estimate being from 
0.3 to 3.0 mg/person/day (Swisher, 1968). For a 60 kg per-
son, this means a maximal daily dose of 0.05 mg/kg. Never-
theless, individual amounts ingested may vary greatly, and 
ma1l!llalian studies to determine the oral toxicity of LAS have 
been performed. Experimentation on rats is extensive, per-
haps because they are hardy animals and are large enough for 
easy biochemical assay. Bornmann and Loeser (1963) mixed 
LAS into the drinking water of rats and found no apparent 
ill effects. Both male and female rats were given 100 ppm 
LAS ad libitum for a period of lOO·weeks; subsequent autop-
sies showed no significant difference from controls with 
respect to organ weights. Similar.results have been obtain-
ed with dietary levels of LAS. In these cases, concentra-
tions of 0.02, 0.1, and 0.5~ LAS were mixed with commercial 
food and given ad libitum.to rats (Paynter and Weir, 1960; 
- . 
Kay et al., 1965). Even the administration by intubation of 
commercial detergents containing 20fo LAS have not shown sig-
nificant toxicity (Snyder et al., 1964). An additional 
. 
study of the effects of 0.02, 0.1, and 0.5~ dietary LAS upon 
rat reproduction demonstrated no significant differences 
from controls through the F1 and F2 generations. (Buehler et 
al., 1971). 
Toxicological and teratological studies of LAS on 
mice have produced conflicting results. In 1949, Hopper 
_ ... 
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et al., using an early preparation of LAS designated 
Santomerse No. 3, found that the oral Ln50 was 2000 mg/kg in 
mice, as opposed to the 650 mg/kg established by Oser and 
Morgareidge (1965) in rats. Recently, Mikami et al. (1973) 
administered 60 mg/kg of LAS in the drinking water of preg-
nant ICR mice, and reported that litters exhibit.ed one-
third to one-half cleft palate, a small percentage of ex-
encephaly and microphthalmia, and one-third to one half fet-
al death. Another report, by Sakai (1973} of the Mikami 
group, stated that concentrations of as low as 0.015 mg/kg 
LAS produced cleft palate, spina bifida, and anencephaly in 
a percutaneous study on ICR/JCL mice. However, Palmer et al. 
(1973} also applied LAS to the skin of ICR CD-1 mice in con-
centrations of 0.03, 0.3, and 3.0%. He found that at 3.0%, 
an 80% implantation loss occurred.along with a decrease in 
normal weight gains during pregnancy. Minor skeletal var-
iations were the most cormnon abnormality, but they were 
within "laboratory limits". A more recent work by Pelmer 
et al. (1975) reported that no teratogenesis was evident in 
CD-1 mice that had been given 0.2, 2.0, 300, and 600 mg/kg 
of LAS by intubation from days 6 to 15 of gestation •. How-
ever, maternal toxicity was evident at the 600 and 300 mg/kg 
doses. 
Although these results appear conclusive with respect 
to the teratogenic potential of LAS, the basis for the re-
testing of LAS in mammalian systems is based upon several 
r 
recent findings. Manner and Dewese (1974) demonstrated 
that an 11.8 LAS preparation produced neural anomalies in 
Zebra fish, Brachydanio rerio, at concentrations of less 
than 5 ppm. Curvature of the spine, anophthalmia, micr-
ophthalmia, and even deaths were observed when the embryo 
had been exposed at the late cleavage stage of development. 
These results were consistent with those of Mikami et al. 
10 
( 1973), who had reported that 60 mg/kg of orally administer-
ed LAS produced exencephaly, microphthalmia, cleft palate, 
and even fetal death in ICR/JCL mice. The previously des_.. 
cribed results had not been reported in fish, mice, or rats. 
Palmer~~· (1975), in reassessing the teratogenic pot-
ential of LAS upon mice, rats, and rabbits, found the rat 
to be more tolerant of the surfactant than other species. 
Since generalizations regarding lack of teratogenesis of LAS 
toward rats had been projected to include all mammals,· there 
is now doubt regarding the validity of such a conclusion. 
Further, the procedure employed by Palmer had been to dose 
the animals after blastocyst implantation. The teratogenic 
potential of LAS administered during early mammalian embryo-
nic development had been overlooked. Manner and Dewese 
(1974) had shown that this period was most susceptible to 
LAS teratogenicity in fish embryos. Thus, their observa-
tions, suggesting early stages of embryogenesis are most 
susceptible to LAS teratogenicity, form a working hypothesis 
to be tested in mammals. 
--
MATERIALS AND METHODS 
Two basic differences from the majority of toxicol-
ogical work done with LAS were employed here. First, the 
mode of administration, intubation, is used infrequently ex-
cept for the detennination of Lo50 values; however, it pro-
vides a more accurate record of the amount of material which 
the animal has received. Second, ch.ronic or prolonged doses 
were used instead of dividing the gestation period into sec-
tions and administering the dose only at specific times 
(King et al., 1972). The amount of time. available to study 
' --
a given number of animals was the limiting factor of this 
method. 
One ambiguity of teratology is th~ distinction be-
tween physic.al and functional anomalies. In the examina-
tion of fetuses, only physical defects were considered, 
since functional deviations often take time to verify, a ~-
process which can take place only if the fetuses are living. 
General Procedures 
Forty-two day old virgin ICR CD-1 mice were obtained 
from the Charles River Breeding Laboratory, Wilmington, 
Massachusetts, and allowed to mature to 2~ months of age 
before experimentation. Throughout the study, two to four 
animals were housed in plastic shoe-box type cages (6~ x 11 
11 
. ®12 
in.) containing an inert bedding material called Sanicel ~. 
Purina Mouse Chow for Breeding Mice ® and tap water were 
given ad libitum, with distilled, deionized water being sub-
stituted for tap water during experimentation. Fresh water 
was provided every other day; water bottles and cages were 
cleaned weekly. A mild Alconox ® solution was employed dur-
ing cleaning, followed by 6-10 rinses under running tap 
water. Temperature was regulated at 22 ± i 0 c under a 12 
hour cycle and a relative humidity of 50 ± 10%. 
Females were exposed to males overnight in a ratio of 
3-4 to 1. Presence of vaginal plugs or sperm in vaginal 
smears were taken as indications of fertilization and this 
day was designated day 0 of gestation. Pregnant mice used 
for experimentation were separated from stock females and 
grouped according to dose. 
Sodill\~ dodecylbenzene sulfonate having an average 
carbon length of 11.e was provided by the Procter and Gamble 
Co., Cincinnati, Ohio. The test material was an off-white 
paste whose composition was assayed as 57.5% active· sodium 
dodecylbenzene sulfonate, 2-3% unreacted alkylbenzene, 0.91% 
sodium sulfate, and a remaining fraction of water. A cor-
rection factor of 1.74 was used in calculating doses to ad-
just to 100% activity. The test ~aterial was refrigerated 
to maintain consistency, but was allowed to come to room 
temperature before weighing. Since small amounts were 
needed, a factor of 10 was employed to insure accuracy to 
13 
within 0.5 mg; the volume of distilled, deionized water 11;as 
also adjusted by a factor of 10. Concentrations of LAS ad-
ministered were in relation to body weight to allow compari-
son with other species; all amounts varied according to the 
daily weight changes of the animal. Vials used for weighing 
were thoroughly rinsed and dried beforehand; suspensions 
were mixed with a teflon stir;ri.ng bar. A gavage needle was 
fanned from a 17 gauge needle by making a small bend at the 
open end and attaching a ball of lead solder. The needle 
was thoroughly rinsed before and after each intubation, and 
a fresh. plastic 1 cc syringe was used each day. Single, 
daily doses were administered at.12:00 P.M. + 2 hours. 
All animals were killed by excess etherization, the 
uteri excised, fetuses checked for movement, and uteri plus 
contents weighed; indj_ vidual fetal weights were not taken. 
Two-thirds o~ the fetuses from each litter were placed into 
vials containing Bouin's solution and allowed to f'ix for a 
period of at least 10 days. One-third of the fetuses were 
placed into 95% ethanol, cleared, and stained with Alizarin 
Red S according to Knudsen (1966). 
Seventeen day old fetuses which had been preserved in 
Bouin's fluid were sectioned according to Wilson (1965). 
This method is used for gross examination; histologic var-
iations were not considered. Fetuses were examined for syn-
dactyly, polydactyly, adactyly, micromelia, phocomelia, 
spina bifida, anophthalmia, microphthalmia, hydrocephaly, 
_ .. 
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anencephaly, exencephaly, cleft palate, incomplete closure 
of the ventricular ca~diac septum, diaphramatic hernia, 
umbilical hernia, position of the aortic arch, number and 
position of the kidneys and adrenal glands, and the presence 
of gonads. In addition, the volume of each fetus without 
umbilicus was measured by water displacement as an indica-
tion of relative size. Fetuses stained with Alizarin Red S 
were examined for number of ribs, cervical vertebrae, stern-
al vertebrae, digits,. ossification of vertebrae centrae, and 
general skeletal anomalies. 
Range Study 
Early in the research it had become apparent that the 
high dose of 300 mg LAS/kg maternal body wei,ght was inter-
fering with nonnal gestation. A range of doses was there-
fore tested to detennine at what level implantation would 
occur. Pregnant females were randomly divided into groups 
and administered 0.25 ml of a LAS-distilled, deionized water 
suspension by intubation on a daily basis from day 9 to 7 of 
gestation. Doses from JOO to 100 mg/kg at 25 mg/kg incre-
ments were used with the addition of a 50 and 0 mg/kg dose 
to complete the spectrum of doses.· Control~ received 0.25 
ml of the vehicle without LAS. 
Females were killed on day 8 of gestation and the 
number of implants recorded. A minimum of three mice either 
bearing or lacking implants was taken as sufficient indica-
tion of toxicity for each dose. Sectioning of embryos was 
not possible due to small embryonic sizes at this early 
stage of development. 
Term Study 
15 
Pregnant females were randomly distributed into 
groups receiving 225, 100, and 5 mg LAS/kg body weight and 
controls. The teratogenic activity of JOO mg/kg of sodium 
sulfate was also tested in a preliminary study upon 5 dams; 
the results showed no significant abnormalities when com-
pared with controls (Table I). This dose was chosen to com-
pare the effects of sodium sulfate with an equal concentra-
tion of LAS. Also, since only 0.91~ of the LAS preparation 
was sodium sulfate, the level administered in the dose is 
well below the lowest normal sulfate concentration in the 
blood (Guyton, 1971). Sodium sulfate was then minimized as 
a teratogenic possibility. 
All mice were placed into cages with animals receiv-
ing the same dose level. Experimentals received 0.20 ml ~-
LAS-distilled, deionized water suspension, while controls 
received 0.20 ml distilled, deionized water. Animals were 
gavaged for 17 days beginning on day o, and killed on day 17 
of gestation. Fetuses were scored, placed in appropriate 
solutions, and examined in the manner outlined previously. 
Records were kept of the anomalies and resorptions found in 
each litter. The Kruskal-Wallis test, Wilcoxon Rank test, 
and the Chi square test were used to ascertain statistical 
significance of the results (Sokal and Rohlf, 1969). Non-
para~etric values such as litter data are particularly 
suited to the Kruskal-Wallis and Wilcoxon tests, while Chi 
square is a well established test of frequencies. 
16 
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RESULTS 
Table I shows the results of oral administration of 
300 mg sod:lum sulfate/kg body weight. The observation of 
one fetus with cleft palate does not appear to be terato-
genically significant, since cleft palate is the most com-
mon sporadic visceral defect with a high incidence in this 
strain of mice (Palmer, 1972). 
Table II presents the results of the range study. It 
can be seen that of the concentrations of LAS used, 225 mg/kg 
was the upper limit of surfactant which allowed the number 
of implantations of blastocysts of experimentals to approx-
imate that of the controls at almost every dose level below 
225 mg/kg. Because of borderline maternal toxicity at 200 
and 225 mg/kg, more than 3 experimental animals were requir-
ed to ascertain toxicity. Dams receiving concentrations of 
250, 275, and 300 mg/kg failed to exhibit implantation of 
blastocysts. Maternal toxicity rather than embryotoxicity 
is believed to have caused interference with the nonnal pro-
cesses involved in fe,."'tilization and development leading to 
implantation, since the usual $igns of maternal ~oxicity 
such as weight loss and diarrhea were evident. Since 225 
mg/kg was the highest tolerable dose, it was used as the 
17 
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TABLE I 
RESULTS OF ADMINISTRATION OF 300 mg Na2so4/kg BODY WEIGHT 
NUMBER OF LITTER PERCENTAGE 
LITTERS SIZE RESORBED AND 
± S.D. DEAD FETUSES 
+ S.D. 
3* 13.0+0.7 2.8+4.8 
2*** 11.0+l.O 0 
LITTER WEIGHT 
(gm) ± S.D. 
21.63±2.7 
5.57+1.1 
NUMBER OF 
FETUSES 
EXAMINED 
39 
22 
NUMBER OF 
FETUSES 
AFFECTED 
l** 
0 
* Pregnancies terminated on day 18 of gestation. Animals dosed from day 0 to 17 
of gestation. 
** Fetus exhibited cleft palate. 
*** Pregnaneies terminated on day 13 of gestation. Animals dosed from day 0 to 
12 of ge9tation. 
I 
\ 
~ 
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TABLE II 
RANGE STUDY: LEVELS OF LAS AFFECTING NUMBER OF IMPLANTS 
DOSE (mg/kg) 0 50 100 125 150 175 200 225 
SAMPLE SIZE 9 4 4 3 4 3 6 5 
AVERAGE IMPLANTS 
OF VIABLE LITTERS 12.4 13.3 12.3 13 15 14.6 15 11 
+ S.D. ±3.3 +0.6 +2.S +2.0 +l.O +1.2 +1.0 +2.6 
-
NUMBER NOT 1 1 1 0 1 0 3 2 PREGNANT 
Presented are the results of the range study in which dams received 0.25 ml LAS-
vehicle from day 0 to 7 of gestation. These results show the average number of 
implants observed on day 8. The "number not pregnant" is the number of confinned 
matings which on examination did not bear blastocyst implants. The "sample size" 
represents all confirmed matings. 
I 
' 
I-' 
'° 
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highest dose in the 17 day study; 100 mg/kg represented 
the mid-region of the range; and 5 mg/kg was a close ap-
proximation of the amount of normal intake (Swisher, 1968). 
Experimental parameters are summarized in Table III, and 
include values for litter size, in utero litter weight, 
fetal volume, and the percentage of dead and resorbed 
fetuses of viable litters. As can be seen, the litter 
sizes and weights, as well as fetal volumes, are all over-
lapping values and therefore not statistically different 
from the controls. Although the percentages of dead and 
resorbed fetuses overlap and were not significantly differ-
ent from controls, a trend toward increasing embryotoxicity 
with increasing concentratio~s of LAS administered is seen. 
Also, 5 of the fetal deaths at 225 mg/kg represent retarded 
growths, whereas no retarded growths were observed in the 
controls or any other group. Possible embryotoxicity a-::, 
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225 mg/kg is further evidenced by the number of females not 
bearing litters. None of the aforementioned signs of mater-
nal toxicity were preserit. 
Although a similarly high number of non-pregnancies 
is seen in the control group, they may reflect a non-random 
selection of fema~es by the experimenter. In these cases, 
although copulation had occurred, the likelih.ood of preg-
nancy may have been diminished due to a decreased sperm con-
centration in the semen. 
It should be noted that although the percentage of 
...... 
DOSE 
rngLAS/ 
kg BODY 
WEIGHT 
0 
5 
100 
225 
NUMBER OF DAMS 
BEARING VIABLE 
YOUNG/NUMBER OF 
CONFIRMED PR?G-
NANCIES 
15/21 
13/15 
12/15 
13/21 
TABLE III 
FETAL AND LITTER PARAMETERS 
AVEHAGE 
LITTER 
SIZE 
± S.D. 
12.00±2.9 
12.54+1.9 
13.00±1.9 
12.69+2.9 ' 
PERCENTAGE 
RESORBED AND 
DEAD FETUSES 
+ s.n. 
4.17±5.8 
4.37±5.4 
5.66+5.6 
10.77±9.7 
AVERAGE 
LITTER 
WEIGHT( gm) 
+ S.D. 
-
18.5±3.7 
18.1+2.8 
17.8±2.7 
18.0±J.5 
AVERAGE 
FETAL 
VOLUME(ml) 
+ S.D. 
1.03+0.14 
0.99+0.09 
0.95+0.12 
0.97+0.12 
Presented are the fetal and litter parameters of dams in the 17 day study which received 
either 0.20 ml 'LAS-vehicle or 0.20 ml vehicle alone beginning on day 0 of gestation. 
I'\) 
I-' 
~ 
r 
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dead and resorbed fetuses differ between control and ex-
perimental groups, all other parameters are compar~ble. 
Thus the production of anomalies in the experimental groups 
does not appear to have been influenced by maternal factors 
or diet. 
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The only visceral anomalies detected using Wilson's 
sectioning techniques (1965) were 1 hydrocephalus (Figure 
2), 2 cleft palates (Figure 4), and one case of misposition~ 
ing of the aortic arch. The 4 affected fetuses were of 110 
examined in the 225 mg/kg group. No visceral defects were 
found in any of the 144 fetuses in control, 115 fetuses in 
the 5 mg/kg, or 102 fetuses in the 100 mg/kg groups. The 
placenta of one fetus with cleft palate was fused with the 
placenta of the neighboring fetus; how this may have in-
fluenced the production of the cleft is analyzed in the 
discussion. Five fetuses in the 225 and 100 mg/kg groups 
exhibited underdeveloped he.arts, but it was .not clear 
whether these represented miscounted fetal deaths or ab-
normalities; these data were not incluaed. 
Results of skeletal examinations are summarized in 
Table IV, which tabulated the incidence of extra ribs, un-
ossified 5th sternebrae (Figure 6), and incomple~e fusion 
of sternebrae. The latter abnormality was designated as 
"dumbbell shaped" (Figure 7). The colu.."nll marked "Other" 
tabulated unfused sternebrae other than the 5th. In 
assessing the skeletal anomalies, some attention must be 
.-
Figure shows a picture of a longitudinal section 
through a brain suspected as having hydrocephalus. 
Enlarged lateral ventricles are characteristic of 
hydrocephalus. 
Figure 2 
Figure shows a picture of a longitudinal section 
through a normal brain. 
Figure 3 
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Fig.2 
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Fig. 3 
Figure shows a picture of a fetus with cleft 
palate. 
Figure 4 
Figure shows a picture· of a nonnal palate. 
Figure 5 
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Fig. 4 
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Fig . 5 
DOSE 
(mg/kg) 
0 
5 
100 
225 
NUMBER OF 
FETUSES 
EXANIINED 
31 
39 
38 
35 
NUMBER OF 
FETUSES 
AFFECTED 
17 
18 
15 
13 
TABLE IV 
SKELETAL VARIATIONS 
PERCENTAGE 
FETUSES 
AFFECTED 
54.84 
46.15 
39.47 
37.14 
EXTRA 
RIBS 
12 
12 
6 
6 
UNOSSIFIED 
5th 
STERNE BRAE 
2 
2 
8 
4 
* Dumbbell fonnations at the second and fourth sternebrae. 
DUMBBELL 
SHAPED 
5 
4 
0 
3 
OTHER* 
1 
2 
2 
2 
The data represents the incidences of observed skeletal variations of fetuses stained 
with Alizarin Red S. 
N 
Vt 
-........... 
Figure shows a picture of a fetus with no 
ossification of the 5th sternebra. 
Figure 6 
26 
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Fig. 6 
Figure shows a picture of a fetus with incomplete 
fusion of the 2nd and 5th sternebrae; these were 
designated "dumbbell shaped". 
Figure 7 
27 
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Fig. 7 
2$ 
paid to normal variations 'tihich occur within a population. 
For example, Palrner (1972) describes extra ribs as· such a 
variant with no particular significance to teratogenic 
activity. For this reason, the skeletal variations observed 
do not appear to be in any way related to LAS administrat-
ion. 
Table V lists multiple defects and the distribution 
of anomalies within groups and litters. The purpose of this 
table is to assess the occurrence of related anomalies and 
litter effects. No instances of litter effects or multiple 
visceral anomalies in one fetus were found. The occurrence 
of multiple skeletal defects is due to the high incidence 
of extra ribs. Omission of these values of extra ribs 
decreases the number of fetuses with multiple defects to o. 
A random distribution is seen in the number of affected 
litters. 
. .. 
-.... 
TABLE V 
DISTRIBUTION OF ANOMALIES 
VISCERAL ANOMALIES 
DOSE NUMBER OF NUMBER OF NUMBER OF LITTERS NUMBER OF LITTERS 
(mg/kg) FETUSES WITH AFFECTED WITH 2-3 FETUSES WITH 4 OR MORE 
MULTIPLE LITTERS/TOTAL WITH SAME DEFECT FETUSES WITH SAME 
DEFECTS NUMBER OF DEFECT 
LITTERS 
0 0 0/15 0 0 
5 0 0/13 0 0 
100 0 0/12 0 0 
225 0 4/13 0 0 
SKELETAL ANOMALIES 
0 3 7/8 4 l* (extra ribs) 
5 2 .S/11 7 0 
100 1 9/11 4 0 
225 2 5/10 1 l* (extra ribs) N 
'° 
\ 
DISCUSSION 
In evaluating the data for teratogenicity, the firm 
establishment of nonnal incidences of malformations is re-
quired. Data from this experiment have not provided enough 
background data of frequencies of sporadic anomalies to 
allow acceptable statistical analysis. However, when com-
pared to 2.23 hydrocephalic mice per 10,000 fetuses and 
45.56 mice with cleft palate per 10,000 fetuses for sporadic 
incidences of anomalies (Palmer, 1972), differences to the 
225 mg/kg group are observed. Although these values may be 
statistically significant, they are not teratogenically sig-
nificant, since the values are low enough to be within nor-
mal limits of a population (Wilson, 1975, personal communi-
cation) and they do not stress one single defect or related 
defects. The administration of LAS may have only slightly 
exceeded the threshold for these common anomalies (Fraser, 
1971). However, conclusions will be drawn later. 
Making a distinction between nonnal and hydrocephalic 
fetuses was quite difficult, since the development o.f the 
lateral ventricles was not completed at this developmental 
stage (Figures 2 and 3). Examination o.f a representative 
section of a .fetus with hydrocephalus did not confirm this 
30 
... 
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interpretation (Wilson, 1975, personal communication). The 
scoring of cleft palate did not have this ambiguity; the 
observed clefts were clear (Figures 4 and 5). In one case 
of observed cleft palate, the placentas of a malformed fetus 
and its neighbor were fused. This fusion of placentas could 
have contributed to the fonnation of the cleft; a fetus with 
decreased placental supply may lack the necessary metabo-
lites for proper palatal closure (Fraser, 1971). A similar 
occurrence of placental fusion in the same litter produced 
one normal and one underdeveloped fetus. 
The relationship of anomalies to sex and uterine 
position have been explored. Of a total of 207 male and 
204 female fetuses examined, males show a higher incidence 
of anomaly than females (4 to O). This observation sug-
gests that males exhibit a higher susceptibility toward such 
anomalies than females, but lack of sufficient numbers of 
affected fetuses warrants caution not to overstate this ob-
servation. The uterine positions of abnormal fetuses in the 
examined litters appeared to be random. 
The mechanism of LAS action on the fetus is difficult 
to ascertain. The development of cleft palate may be in-
fluenced by a decrease of amniotic fluid which produces 
clefts by overconstriction of the fetus, or a decrease in 
availability of mucopolysaccharide necessary for palatal 
closure (Fraser, 196g). Overconstriction of the fetus 
presses the tongue against the palatal shelves, thereby 
... 
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preventing their union. Mucopolysaccharides are necessary 
for shelf extension and growth. The mechanism by which LAS 
produces cleft palates depends largely on placental transfer 
of the compound which has not yet been proven. Assmning 
gastro-intestinal absorption, placental transfer might re-
sult in solubilization of mucopolysaccharide. It should be 
noted that for th1.s mechanism to operate the concentration-
of the surfactant must be sufficient to overcome excretion 
by the kidney and oxidative degradation into products which 
lack surfactant properties (Michael, 1968). 
Hydrocephalus may be produced by or1e of three mech-
anisms: overproduction of cerebrospinal fluid (CSF), de-
fective absorption of CSF, or obstruction of CSF drainage 
(Fishman, 1971). Little is known about the overproduction 
of CSF, but defective absorption can be caused by high CSF 
protein concentration which decreases the absorption 
through the arachnoid villi. Obstruction of CSF pathways 
can be at the level of the ventricular aqueduct (n-:m-com-
munica~in5 hydrocephalus) or at the level of the spinal 
subarachnoid space (communicating hydrocephalus) (?oley, 
1974). Excess amounts of amniotic fluid may also play a 
significant role in the formation oi' hydrocephaly (Posner, 
1972). However, since only one case of mild.hydrocephalus 
was observed, discussion of the mode of action by which LAS 
produces hydrocephaly appears moot. 
There appear to be two periods of gestation during 
... 
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which the embryo or fetus is most susceptible to the action 
of LAS. One period of embryo susceptibility is seen in the 
term study, in which a high number of early resorptions was 
observed at 225 mg/kg. This period is essentially the first 
trimester of gestation. Susceptibility during this time may 
be due to the presence of a yolk sac placenta (Bellairs, 
1971) and fetal deaths might be a result of the denaturation 
of membrane or nutrient protein by LAS (Yang and Foster, 
1953). It should be noted that large concentrations of the 
surfactant are not necessary for protein-surfactant complex 
formation (10.5 x 10-5M). The occurrence of fetal deaths 
after early exposure of the embryo to LAS corresponds to the 
observation of Manner and Dewese (1974) in fish. Such ob-
served deaths and anomalies after early exposure to the sur-
factant may be related to yolk protein-surfactant complex-
ing. 
The second period of susceptibility to LAS may affect 
early fetal development as illustrated by the clef~ palates, 
hydrocephalus, and retarded growths. The critical period 
for the production of cleft palate and hydrocephaly excom-
passes the early portion of the last trimester (Dagg, 1966; 
Rugh, 1968), a time which would correspond to th_e develop-
mental age of many of the retarded growths observad at the 
225 mg/kg dose. Although the formation of 
thelial placenta 
tibility to LAS may again be influenced 
... 
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sac placenta. 
One question that can be posed at this time is why 
such varying results have been reported in many mammalian 
studies. It is known that the results of any toxic or 
teratogenic study are always dependent, to some extent, on 
mechanical or procedural factors such as time and method of 
administration of teratogen (Halberg, 1974; Haus et al., 
1974). An important factor is the particular type of LAS 
preparation tested, which can vary with respect to chain 
length and positional isomeric composition from manufacturer 
to manufacturer. Variable composition may account in part 
for varying levels of toxicity in mammals; such variances 
have been documented in fish (Hirsch, 1963; Borstlap, 1964; 
Manner and Dewese, 1974). 
An equally important factor is the timing of admini-
stration, not only with respect to gestation, but also with 
respect to circadian rhythm (Halberg, 1974). It has been 
reported that varying degrees of drug susceptibility are 
present at different times of the circadian rhythm (Haus et 
al., 1974). Thus, the time in the animals natural rhythm 
at which the dose is administered may play a significant 
role in obtaining varying results. 
Timing ir1i th respect to the gestation period may also 
influence results. For example, Palmer ~ al. ( 1975), using 
methods approximating the ones employed here, gavaged ICR 
CD-1 mice ·with an LAS preparation on days 6 to 15 of gesta-
.-
tion. Deaths occurred in 19 of 20 mice at 600 mg/kg and 
7 of 20 mice at JOO mg/kg. In the latter group·, only 9 of 
the 13 surviving dams bore young. At dosages of 2.0 and 
0.2 mg/kg, no toxicity was evident in darns or their off-
spring. Results of the present experiment indicate that 
LAS administered during the first 6 days of gestation was 
sufficiently toxic at levels above 225 mg/kg to interfere 
with the processes leading to normal blastocyst implanta-
ti on. 
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The mode of administration employed in any terato-
genic study often reflects actual means of exposure and 
greatly influences the results. Percutaneous studies which 
assume primary exposure to the compound have shown both 
positive and negative results (Sakai, 1973; Palmer, 1973). 
However, absorption through the skin may be minimal in 
comparison with other modes of administration (Gale, 1974). 
One striking example of the effects of different modes of 
administration can be seen in a comparison of oral versus 
intraperitoneal administration levels; a 5 fold difference 
exists in the dose of surfactant that can be tolerated for 
normal implantation (David et al., 1975, manuscript submit-
ted for review). The cause of this difference is not known, 
but several possibilities exist: metabolic inactivation of 
the compound by omega- followed by beta-oxidation (Michael, 
1968), a slow rate of absorption through the gastro-intest-
inal tract (Michael, 196$), or a combination of factors 
including rate of placental transfer (Villee, 1965; Wilson, 
, .. 
1973). VJhatever the mechanism, it is evident that ex-
tremely large a.'ilou.."1.ts of oral LAS were necessary ~o produce 
effects similar to those obtained with other methods. 
Conclusions 
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The primary question of the present research has been 
to ascertain the teratogenic potential of LAS in ICR CD-1 
mice. The hypothesis that LAS is teratogenic in mice is 
suggested only by the data of embryotoxicity at the 225 mg/kg 
level, since fetal deaths and resorptions may represent 
embryotoxicity produced by teratogenicity {Beck and Lloyd, 
1963). However, this embryotoxic activity may correspond 
only to the presence of the yolk sac placenta. The later 
f onnation of the heme-endothelial placenta characteristic 
of rodents apparently acts as a sufficient barrier to pre-
vent any teratogenic activity by the surfactant. The ob-
servation of a few common visceral defects at the 225 mg/kg 
dose may reflect 1) the lower tolerance of a few dams, or 
2) a nonnal incidence of defects in a population. In 
either case, the defects were not considered to be·terato-
genically significant. 
An underlying question, however, concerns the poten-
tial hazard to humans. As mentioned in the introduction of 
this paper, species tolerance to various compounds plays a 
significant role in evaluating teratogenic potential. Such 
a problem can be illustrated by the results obtained by 
Palmer~ al. (1975) in which CD rats and CD-1 mice were 
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intubated with comparable concentrations of LAS. It was 
found that 600 mg/kg was lethal to 19 of 20 mice, while not 
lethal to any rats. Similarly, while JOO mg/kg had no ef-
feet on rats, 7 of 20 mice died, with 4 of the survivors 
failing to bear young. Explanations which cite the size of 
the animal as the sensitivity factor were untenable, since 
. NZW rabbits also used in the study showed responses to LAS 
which were comparable to those obtained from mice. Results 
of a comparable nature have been reported for other com-
pounds (Schumacher et~., 1972). The effects of such 
species tolerance, particularly of the rat, are secondary 
to this study, but in assessing LAS teratogenicity to 
humans, such resistance of a widely used test animal com-
plicates any conclusions to be drawn from the available 
data. However, the environmental hazard of LAS to humans 
appears minimal, since 1) levels of LAS in the environmental 
watershed are low, due to rapid degradation by sewage bact~ 
eria (Swisher, 1963; Halvorson and Isaque, 1968); 2) fairly 
low levels of LAS are consumed in comparison to body weight 
(Wedell, 1966; Sir1isher, 1968); and 3) any LAS.which is in-
gested is metabolized and excreted into the urine (Michael, 
1968). Further, the adverse effects found in mice were 
-
within the theoretical teratogenic range of the compound 
(Wilson, 1973), ·with the dose closest to physiological 
levels demonstrating no effect. It can only be concluded 
that at levels currently found in water supplies, 11.8 LAS 
38 
poses no teratogenic hazard to humans. 
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Kruskal-Wallis test 
Detennination of significance of percentage of de.ad and 
resorbed fetuses. 
Value Rank Value Rank Value Rank 
0 12.5 0 12.5 13.33 45 
0 12.5 0 12.5 13.33 45 
0 12.5 6.25 25 13.33 45 
0 12.5 6.66 2$ 14.29 48 
0 12.5 6.66 2$ 15.38 49.5 
0 12.5 6.66 28 15.38 49.5 
0 12.5 6.66 28 25 51.5 
0 12.5 6.66 28 25 51.5 
0 12.5 7.14 32 28.57 53 
0 12.5 7.14 32 
0 12.5 7.14 32 
0 12.5 7.69 36 
0 12.5 7.69 36 
0 12.5 7.69 36 
0 12.5 7.69 36 
0 12.5 7.69 36 
0 12.5 8.33 39 
0 12.5 9.09 40.5 
0 12.5 9.09 40.5 
0 12.5 11.11 42 
0 12.5 13.33 45 
0 12.5 13.33 45 
46 
Kruskal-1:lallis test (cont.) 
Stun of ranks within groups. 
Control 5 rng/k~ 100 mg/kE; 225 mg/kg 
12.5 12.5 12.5 12.5 
12.5 12.5 12.5 12.5 
12.5 12.5 12.5 12.5 
12.5 12.5 12.5 2$ 
12.5 12.5 12.5 2$ 
12.5 12.5 2$ 36 
12.5 12.5 28 36 
12.5 28 36 39 
12.5 32 40.5 42 
25 36 40.5 45 
32 36 45 51.5 
32 45 49.5 51.5 
45 48 330 53 
45 312.5 447.5 
49.5 
341 
Calculation of 11H". 
12 
H= (53 )( 54) 
2 2 2 . i 
( 341 312.5 330 447.5 3(54) ~ + 13 + -rz- + 1) -
H 
Hadjusted = D 
Reale = 5.1287 
14202 
D = l - (52)(53)(54) 
Critical H (p = 0.05) = 7.815 
Anomalous 
Expected= 
Observed= 
Normal 
Expected= 
Observed= 
Total= 
Chi square test 
Determination of significance of skeletal defects. 
Control 
13.65 
17 
17.35 
14 
31 
5 mg/kg 
17.16 
18 
21.84 
21 
39 
100 mg/kg 
16.72 
15 
21.28 
23 
38 
225 mg/kg 
15.14 
13 
19.6 
22 
35 
Total 
Observed 
63 
80 
143 
Expected Anomalous = ~ (Total of group) 
Expected Normal = Total of Group - Expected Anomalous 
' Calculated Chi square = 2.52 Critical Chi square (p = 0~05) = 7.815 
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